Alejandra Garitonandia

Alejandra Garitonandia

Industry Principal for Life Sciences at Vistex EMEA

More posts by Alejandra Garitonandia

profit sharing agreements featured image

How Life Sciences Leaders Use Profit-Sharing Agreements to Manage Risk and Drive Growth

How are life sciences leaders using profit-sharing agreements to manage risk and drive growth? Explore the strategy, structures, and capabilities required.

March 30, 2026

Read More...

The Glocalization Imperative Why Life Sciences Must Master Global-Local Strategic Balance featured image

The Glocalization Imperative: Why Life Sciences Must Master Global-Local Strategic Balance

At a recent pharmaceutical industry roundtable, I watched executives grapple with a fundamental tension: how to maintain global efficiency while meeting increasing local demands.

October 14, 2025

Read More...

Beyond the AI Panacea: Real Solutions for Life Sciences featured image

Beyond the AI Panacea: Real Solutions for Life Sciences

At a recent life sciences conference, I counted the sessions focused on AI — 90%. Every conversation, presentation and networking discussion circled back to AI as the ultimate solution.

June 23, 2025

Read More...

Parallel Trade featured image

The Undertow Threatening Your Pricing Strategy: Parallel Trade

What if your carefully curated pricing strategy, tailored to regional economic conditions and market demands, was washed away by someone else profiting from the difference?

March 7, 2025

Read More...

GtN visibility in life sciences feature image

Clear Skies Ahead: Breaking Through The Gross-to-Net Fog

In the complex life sciences landscape of financial and commercial operations, gaining clear visibility into your Gross-to-Net (GtN) process is no longer a “nice-to-have” – it's fundamental to making strategic business decisions.

November 11, 2024

Read More...

Redefining Digital Transformation: A Vital Strategy For Life Sciences

Redefining Digital Transformation: A Vital Strategy For Life Sciences

Digital transformation is now a pivotal lever for growth and innovation in the life sciences industry. Various influences – from pricing pressures to more stringent compliance and operational siloes are changing the landscape, especially for pharma and MedTech.

June 21, 2024

Read More...

Medical Device Innovation feature image

On The Edge Of A New Frontier

You don’t need to look far to see that medical device innovations are the “new frontier” of the Life Sciences industry.

March 13, 2024

Read More...

medical device pricing strategies featured image

The Margin Squeeze Trap: Growing Tighter For The Medical Device Industry

Implementing the right pricing strategies for medical devices is crucial for achieving optimal profit margins.

October 16, 2023

Read More...

what is digital health

Doctor Byte: What’s Next In Digital Health And Digital Therapeutics (DTx)

What are digital health and digital therapeutics, and what role do medical device and pharma companies play? 7:00 in the morning my watch reminds me that yesterday I reache...

June 2, 2023

Read More...

Commercial Policies Framework feature image

Your Next Profit Booster: A Healthy Dose Of Commercial Policies Framework

The importance of commercial policies framework in Life Sciences Did you know you can boost margins and profits beyond controlling pricing and contracts in sales? A healthy dose of a...

April 10, 2023

Read More...

Mining Life Science Data

Are You Mining Your Data, Hoping For Gold, And Getting Dirt?

Data is the new currency in Life Sciences and analytics is the pot of gold What if what you think you know just ain’t so? Mark Twain is credited with saying: “It ain’t what...

January 3, 2023

Read More...

CDM CDMO Partnership

Riding The CMO/CDMO Collaboration Wave

CMO and CDMO partnerships are gaining momentum The Life Sciences industry was always viewed as a stable industry until the 2007-2009 economic downturn brought about interes...

June 7, 2022

Read More...

3 ways to manage return and recall pricing

To Return, Or Not To Return, That Is The Question

Return management in pharma: finding the right price Returns on drugs and medical devices are inevitable. Pricing a returned product is not an easy task for pharma and medi...

November 15, 2021

Read More...

Chess anyone? Life Sciences Industry Trends in 2021 and Beyond

Chess anyone? Life Sciences Industry Trends in 2021 and Beyond

Now that the new year is upon us, I’m looking ahead and trying to imagine what new opportunities and challenges we’ll face in Life Sciences. At times like this, when there ...

January 21, 2021

Read More...

Reducing cost and time to market in drug development: The importance of royalties for Pharma and Biopharmaceuticals

Reducing cost and time to market in drug development: The importance of royalties for Pharma and Biopharmaceuticals

Within the last few decades, the cost and time to market for new drug development has soared. Nowadays, it takes an average of 15 years from first molecule investigations u...

April 3, 2020

Read More...